Program

The At-A-Glance program is available for download here.

The full Program is available for download here.

To view slide presentations, please click here to view/download.

Recorded Ple​nar​y Sessions require a password to view. Please contact Megan Rabone at mrabone@fredhutch.org for access.  Once you have the appropriate credentials, please visit our Vimeo page. Thank you!

At-A-Glance program

Invited Speakers:

  • Laura Balzer, PhD, Assistant Professor of Biostatistics, University of Massachusetts, Amherst   
  • Victor De Gruttola, ScD, Professor of Biostatistics, Harvard University
  • David Dunn, PhD, Professor of Medical Statistics, Medical Research Council at University College London  
  • Thomas Fleming, PhD, Professor of Biostatistics, University of Washington, Seattle
  • Dean Follmann, PhD, Chief of Biostatistics Research Branch, NIAID
  • David Glidden, PhD, Professor of Biostatistics, University of California, San Francisco  
  • Jeffrey Murray, MD, Deputy Director of Division of Antiviral Products, Center for Drug Evaluation and Research, FDA
  • Janet Wittes, PhD, President of Statistics Collaborative, Inc.  

Opening Speakers:

  • Glenda Gray, MD, President and CEO, South African Medical Research Council 
  • Jeremiah Johnson, MPH, HIV Project Director, Treatment Action Group
  • Deborah Donnell, PhD, Associate Member, Fred Hutch and Principal Investigator of HPTN Statistical Data Management Center
  • Elizabeth Brown, ScD, Member, Fred Hutch and Principal Investigator of MTN Statistical Data Management Center
  • Peter Gilbert, PhD, Member, Fred Hutch and Principal Investigator of HVTN Statistical Data Management Center

Moderators & Panelists:

Panel: Design challenges and approaches developing long-acting, drug-based prevention products for HIV prevention

  1. Edward Cox, MD, Director of Office of Antimicrobial Products, FDA
  2. Jeremy Sugarman, MD, Professor of Bioethics and Medicine, Johns Hopkins University
  3. Danielle Wenner, PhD, Assistant Professor of Philosophy, Carnegie Mellon University 
  4. Patricia Segura, RN, MPH, Head of the HIV/STI and Hepatitis National Program, Peruvian Ministry of Health
  5. Ernest Hopkins, BA, Director of Legislative Affairs, San Francisco AIDS Foundation
  6. Jim Rooney, MD, Vice President of Medical Affairs, Gilead Sciences

Moderator: Lut Van Damme, PhD, Senior Program Officer, Bill and Melinda Gates Foundation

Panel: Design challenges and approaches for developing vaccines and monoclonal antibodies for HIV prevention

  1. Carol Weiss, MD, PhD, Laboratory Chief and Principal Investigator, Office of Vaccines Research and Review, FDA
  2. Merlin Robb, MD, Program Director for US Military HIV Research Program
  3. Lucio Gama, PhD, Director of Scientific Collaborations, Vaccine Research Center, NIAID
  4. Ames Dhai, PhD, Director of Steve Biko Centre for Bioethics, Wits University
  5. Mark Hubbard, Education Liaison, Tennessee Association of People With AIDS
  6. Joshua Chen, PhD, Global Head of Biostatistics and Programming, Sanofi Pasteur

Moderator: Dale Hu, MD, Chief of Vaccine Clinical Research Branch, NIAID

Panel: Design challenges and approaches for developing removable/short-lasting/on-demand products for HIV prevention

  1. Charu Mullick, MD, Medical Officer, Division of Antiviral Products, FDA
  2. Liza Dawson, PhD, Research Ethics Team Leader, Division of AIDS, NIAID
  3. Morenike Giwa Onaiwu, MAED, Chair, Global Community Advisory Board, AIDS Clinical Trials Group
  4. Jim Pickett, BA, Senior Director of Prevention Advocacy and Gay Men’s Health, AIDS Foundation of Chicago
  5. Jill Schwartz, MD, Medical Director, CONRAD

Moderator: Linda-Gail Bekker, MD, Deputy Director, Desmond Tutu HIV Centre

Panel: Priorities for follow-up research: research priorities, data collection, and funding mechanisms

  1. David Burns, MD, MPH, Chief, Clinical Research Prevention Branch, DAIDS/NIAID
  2. Mary Marovich, MD, Director of Vaccine Research Program, NIAID
  3. Nina Russell, MD, Deputy Director, HIV, Bill and Melinda Gates Foundation
  4. Charles Gombar, PhD, Deputy Director, Strategy and Product Development, HIV, Bill and Melinda Gates Foundation

Moderator: Peggy Johnston, PhD, Independent Consultant, Vancouver BC